Literature DB >> 24715181

PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two prediction scores for the risk of acute lower extremity deep vein thrombosis.

Tudor Radu Pop1, Ştefan Cristian Vesa, Adrian Pavel Trifa, Sorin Crişan, Anca Dana Buzoianu.   

Abstract

AIM: This study investigates the accuracy of two scores in predicting the risk of acute lower extremity deep vein thrombosis. PATIENTS AND METHODS: The study included 170 patients [85 (50%) women and 85 (50%) men] who were diagnosed with acute lower extremity deep vein thrombosis (DVT) with duplex ultrasonography. Median age was 62 (52.75; 72) years. The control group consisted of 166 subjects [96 (57.8%) women and 70 (42.2%) men], without DVT, matched for age (± one year) to those in the group with DVT. The patients and controls were selected from those admitted to the internal medicine, cardiology and geriatrics wards within the Municipal Hospital of Cluj-Napoca, Romania, between October 2009 and June 2011. Clinical, demographic and lab data were recorded for each patient. For each patient we calculated the prior risk of DVT using two prediction scores: Caprini and Padua.
RESULTS: According to the Padua score only 93 (54.7%) patients with DVT had been at high risk of developing DVT, while 48 (28.9%) of controls were at high risk of developing DVT. When Padua score included PAI-1 4G/5G and MTHFR C677T polymorphisms, the sensitivity increased at 71.7%. Using the Caprini score, we determined that 147 (86.4%) patients with DVT had been at high risk of developing DVT, while 103 (62%) controls were at high risk of developing DVT. A Caprini score higher than 5 was the strongest predictor of acute lower extremity DVT risk.
CONCLUSIONS: The Caprini prediction score was more sensitive than the Padua score in assessing the high risk of DVT in medical patients. PAI-1 4G/5G and MTHFR C677T polymorphisms increased the sensitivity of Padua score.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24715181

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  5 in total

1.  Prevalence of factor V leiden, MTHFR C677T and MTHFR A1298C polymorphisms in patients with deep vein thrombosis in Central Iran.

Authors:  Majid Ehsani; Aida Imani; Alireza Moravveji
Journal:  Mol Biol Rep       Date:  2018-05-31       Impact factor: 2.316

2.  Improved utilisation of venous thromboembolism prophylaxis in renal-impaired patients following a clinical pharmacist intervention.

Authors:  Naemeh Nikvarz; Zahra Seyedi
Journal:  Eur J Hosp Pharm       Date:  2019-12-11

3.  Venous Thromboembolism Risk Stratification: The Missing Link in Hospitalized Patients.

Authors:  Ahmed Al-Ogaili; Luis Diaz Quintero; Juan Pablo Salazar Adum; Harry E Fuentes; Joseph Caprini
Journal:  J Atheroscler Thromb       Date:  2018-05-07       Impact factor: 4.928

4.  Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian population.

Authors:  Soudabeh Hosseini; Ebrahim Kalantar; Maryam Sadat Hosseini; Shadi Tabibian; Morteza Shamsizadeh; Akbar Dorgalaleh
Journal:  Thromb J       Date:  2015-11-10

5.  Clinical Validation of the Chinese Version of Patient Completed Caprini Risk Assessment Form.

Authors:  Xiaolan Chen; Hui Deng; Xinjie Tong; Bei Gu; Jingxuan Liu; He Huang; Liwei Ye; Lei Pan; Joseph A Caprini; Yong Wang
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.